Risedronate sodium and Pleurisy - a phase IV clinical study of FDA data
Pleurisy is found among people who take Risedronate sodium, especially for people who are female, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Risedronate sodium and have Pleurisy. It is created by eHealthMe based on reports of 9,452 people who have side effects when taking Risedronate sodium from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
9,452 people reported to have side effects when taking Risedronate sodium.
Among them, 31 people (0.33%) have Pleurisy.
What is Risedronate sodium?
Risedronate sodium has active ingredients of risedronate sodium. It is often used in osteoporosis. eHealthMe is studying from 9,528 Risedronate sodium users for its effectiveness, alternative drugs and more.
What is Pleurisy?
Pleurisy (inflammation of the pleurae, which causes pain when breathing) is found to be associated with 1,595 drugs and 1,084 conditions by eHealthMe.
Number of Risedronate sodium and Pleurisy reports submitted per year:
Time on Risedronate sodium when people have Pleurisy *:
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Pleurisy when taking Risedronate sodium *:
- female: 82.76 %
- male: 17.24 %
Age of people who have Pleurisy when taking Risedronate sodium *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 20 %
- 50-59: 24 %
- 60+: 56 %
Common drugs people take besides Risedronate sodium *:
- Prednisolone: 12 people, 38.71%
- Cymbalta: 12 people, 38.71%
- Solu-Medrol: 7 people, 22.58%
- Colchicine: 6 people, 19.35%
- Mycophenolate Mofetil: 6 people, 19.35%
- Methotrexate: 6 people, 19.35%
- Zolmitriptan: 6 people, 19.35%
- Humira: 6 people, 19.35%
- Enbrel: 6 people, 19.35%
- Zopiclone: 6 people, 19.35%
Common side effects people have besides Pleurisy *:
- Pulmonary Oedema (fluid accumulation in the lungs): 13 people, 41.94%
- Nausea (feeling of having an urge to vomit): 13 people, 41.94%
- Pleural Effusion (water on the lungs): 10 people, 32.26%
- Cough: 9 people, 29.03%
- Chest Pain: 9 people, 29.03%
- Breathing Difficulty: 9 people, 29.03%
- Fatigue (feeling of tiredness): 9 people, 29.03%
- Chills (felling of cold): 9 people, 29.03%
- Pain: 8 people, 25.81%
- Dizziness: 8 people, 25.81%
Common conditions people have *:
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 15 people, 48.39%
- Cellulitis (infection under the skin): 6 people, 19.35%
- Pain: 6 people, 19.35%
- Migraine (headache): 6 people, 19.35%
- Juvenile Rheumatoid Arthritis (joint inflammation in children due to systemic disease): 6 people, 19.35%
- Urinary Tract Infection: 6 people, 19.35%
- Idiopathic Pulmonary Fibrosis (chronic lung disease): 6 people, 19.35%
- High Blood Cholesterol: 6 people, 19.35%
- Interstitial Lung Disease: 5 people, 16.13%
- Disease Complication: 4 people, 12.90%
* Approximation only. Some reports may have incomplete information.
Do you take Risedronate sodium and have Pleurisy?Check whether Pleurisy is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Hirschmann S, Gibel A, Tsvelikhovsky I, Lisker A, "Late-Onset Psychosis and Risedronate Treatment for Osteoporosis: A Case Report", Clinical schizophrenia & related psychoses, 2013 May .
- Ko KD, Cho BL, "Risedronate-related Localized Amnesia in an Elderly Patient with Osteoporosis", Journal of the Korean Geriatrics Society, 2012 Dec .
How severe was Pleurisy and when was it recovered:
Expand to all the drugs that have ingredients of risedronate sodium:
Alternative drugs to, pros and cons of Risedronate sodium:
- Risedronate sodium (9,528 reports)
Common Risedronate sodium side effects:
- Drug ineffective: 1,679 reports
- Joint pain: 1,336 reports
- Pain: 1,256 reports
- High blood pressure: 1,079 reports
- Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints): 1,062 reports
- Fatigue (feeling of tiredness): 1,014 reports
- Diarrhea: 989 reports
- Rashes (redness): 880 reports
- Joint swelling: 787 reports
Browse all side effects of Risedronate sodium:a b c d e f g h i j k l m n o p q r s t u v w x y z
Pleurisy treatments and more:
- Pleurisy (8,382 reports)
COVID vaccines that are related to Pleurisy:
- Pleurisy in Moderna COVID Vaccine
- Pleurisy in Pfizer BioNTech Covid Vaccine
- Pleurisy in Johnson and Johnson Covid Vaccine
Common drugs associated with Pleurisy:
- Methotrexate: 825 reports
- Humira: 670 reports
- Prednisone: 628 reports
- Prednisolone: 441 reports
- Enbrel: 382 reports
- Aspirin: 261 reports
- Remicade: 256 reports
- Omeprazole: 228 reports
- Ibu: 217 reports
- Ibuprofen: 217 reports
All the drugs that are associated with Pleurisy:
- Pleurisy (1,595 drugs)
Common conditions associated with Pleurisy:
- Rheumatoid arthritis: 1,362 reports
- High blood pressure: 360 reports
- Osteoporosis: 242 reports
- Multiple sclerosis: 237 reports
- Pain: 224 reports
- Birth control: 207 reports
All the conditions that are associated with Pleurisy:
- Pleurisy (1,084 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on risedronate sodium (the active ingredients of Risedronate sodium) and Risedronate sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Anafranil and Premature Labor - a second ago
- Enulose and Flushing Aggravated - 3 seconds ago
- Hydroxyzine Pamoate and Myoclonus - 4 seconds ago
- Ribavirin and Rhabdomyolysis - 5 seconds ago
- Pepcid and Plantar Fasciitis - 6 seconds ago
- Ranitidine vs. Rabeprazole - 7 seconds ago
- Furosemide and Infective Myositis - 15 seconds ago
- Herceptin and Menopausal Symptoms - 19 seconds ago
- Bactrim Ds and Abdominal Tenderness - 19 seconds ago
- Ciprofloxacin and Myoglobin Urine Present - 19 seconds ago